Toronto - About 20 percent of critically ill hospital patients - including many with skin and skin structure infections - treated with vancomycin are now at risk of developing nephrotoxicity, a new study shows.
Exploring the Relationship Between Oligodontia and Hair Abnormalities: A Study Overview
The Cutaneous Connection: A Reminder of Patient Impact
Deucravacitinib Demonstrates Sustained Efficacy and Safety in 4-Year Psoriasis Trial
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Soligenix Announces Publication of Promising Comparative Data for HyBryte Synthetic Hypericin for CTCL
Research Highlights the Importance of Screening Patients for Alcohol Use Disorder